RecruitingNCT06644248

AI Model for Cervical Cancer Detection From Colposcopy Images

Development and Evaluation of an Artificial Intelligence Model for Cervical Cancer Detection From Colposcopic Images


Sponsor

Bangladesh University of Engineering and Technology

Enrollment

500 participants

Start Date

Jan 11, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Cervical cancer is a significant health issue, particularly in low-income countries, where late diagnosis and limited access to screenings contribute to high mortality rates. This study aims to develop and evaluate an artificial intelligence (AI) model to analyze colposcopic images for detecting cervical cancer more accurately and efficiently. Colposcopy, a procedure used to examine the cervix for signs of cancer, relies heavily on doctors' expertise, leading to inconsistent results. The current gold standard, colposcopy-directed biopsy, is invasive and can cause complications. The hypothesis is that an AI model can outperform traditional methods in identifying cervical abnormalities, providing a reliable and scalable solution for early detection, especially in underserved areas. By automating the analysis process, the AI model aims to reduce reliance on trained personnel, making cervical cancer screening more accessible and improving early diagnosis and treatment outcomes. The study will create a diverse dataset of colposcopy images from various sources and develop the AI model. The model's performance will be validated in clinical settings, assessing its accuracy in classifying cancer stages and identifying transformation zones. The impact on early detection, patient outcomes, and model usability will be evaluated, as well as its generalizability across different healthcare environments. The goal is to enhance the accuracy and efficiency of cervical cancer screening, ultimately reducing mortality rates and improving patient care.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing an artificial intelligence (AI) model to detect cervical cancer from colposcopy images — a procedure where a doctor uses a magnifying device to closely examine the cervix. **You may be eligible if...** - You are a woman aged 18 or older - You are willing to participate in cervical cancer screening - You are available for a colposcopy examination - You have not had a hysterectomy (complete removal of the uterus) - You have no current or prior diagnosis of cervical cancer - Your relevant medical records are available **You may NOT be eligible if...** - You are currently pregnant - You have severe medical conditions that make colposcopy unsafe or inappropriate - You have severe vaginal bleeding that could affect screening accuracy - This would be a follow-up screening visit rather than an initial one Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTColposcopy

The intervention involves the use of colposcopy, a diagnostic procedure to visually examine the cervix using a colposcope. The procedure includes the application of saline, acetic acid, and iodine solutions to enhance the visualization of cervical tissues and identify abnormalities. The dosage form includes applying these solutions directly to the cervical area. The frequency of the intervention is typically a single session per patient, with the duration of the procedure lasting approximately 10-15 minutes. This study aims to utilize an AI model to analyze the colposcopic images obtained during the procedure to improve the accuracy and efficiency of cervical cancer detection.


Locations(1)

Ibn Sina Medical College Hospital

Dhaka, Bangladesh

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06644248


Related Trials